Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
La Revue Du Praticien
|
May 26, 2009
[Spondylarthropathies]
Fernando Kemta Lekpa, Valérie Farrenq, Pascal Claudepierre
The Journal of Rheumatology
|
November 3, 2005
Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data
Caroline Delaunay, Valérie Farrenq, André Marini-Portugal, et al.
The Journal of Rheumatology
|
January 6, 2006
Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies
Jean-David Cohen, Patrick Cunin, Valérie Farrenq, et al.
Joint Bone Spine
|
April 19, 2011
Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis-factor inhibition
Fernando Kemta Lekpa, Valérie Farrenq, Florence Canouï-Poitrine, et al.
The Journal of Rheumatology
|
April 17, 2012
Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: data from the French AIR registry
Laure Thomas, Florence Canoui-Poitrine, Jacques-Eric Gottenberg, et al.
Rheumatology (Oxford, England)
|
June 15, 2013
Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort
Martin Blachier, Florence Canouï-Poitrine, Maxime Dougados, et al.
Annals of the Rheumatic Diseases
|
August 16, 2012
Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort
Martin Blachier, Bertrand Coutanceau, Maxime Dougados, et al.
Arthritis Care & Research
|
March 26, 2014
Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort
Florence Canouï-Poitrine, Cécile Poulain, Anna Molto, et al.
Arthritis Research & Therapy
|
March 13, 2012
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study
Fernando Kemta Lekpa, Cécile Poulain, Daniel Wendling, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
La Revue Du Praticien
|
May 26, 2009
[Spondylarthropathies]
Fernando Kemta Lekpa, Valérie Farrenq, Pascal Claudepierre
The Journal of Rheumatology
|
November 3, 2005
Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data
Caroline Delaunay, Valérie Farrenq, André Marini-Portugal, et al.
The Journal of Rheumatology
|
January 6, 2006
Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies
Jean-David Cohen, Patrick Cunin, Valérie Farrenq, et al.
Joint Bone Spine
|
April 19, 2011
Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis-factor inhibition
Fernando Kemta Lekpa, Valérie Farrenq, Florence Canouï-Poitrine, et al.
The Journal of Rheumatology
|
April 17, 2012
Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: data from the French AIR registry
Laure Thomas, Florence Canoui-Poitrine, Jacques-Eric Gottenberg, et al.
Rheumatology (Oxford, England)
|
June 15, 2013
Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort
Martin Blachier, Florence Canouï-Poitrine, Maxime Dougados, et al.
Annals of the Rheumatic Diseases
|
August 16, 2012
Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort
Martin Blachier, Bertrand Coutanceau, Maxime Dougados, et al.
Arthritis Care & Research
|
March 26, 2014
Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort
Florence Canouï-Poitrine, Cécile Poulain, Anna Molto, et al.
Arthritis Research & Therapy
|
March 13, 2012
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study
Fernando Kemta Lekpa, Cécile Poulain, Daniel Wendling, et al.
Page
of 1